It was reported that on (b)(6) 2014, a 29mm epic valve was successfully implanted in the mitral valve of a patient.On 07 june 2022, the 29mm epic valve was explanted due to patient becoming easily fatigued and echography showing signs of mitral regurgitation.During the explant procedure it was noted that a cusp on the 29mm epic valve was perforated.Pannus was also noted on the posterior leaflet of the 29mm epic valve.A non-abbott replacement device was successfully implanted.The patient remained hemodynamically throughout the procedure.There was no clinically significant delay in procedure reported.The patient was stable and starting rehabilitation at the time of report.
|
Explant due to patient fatigue and signs of mitral regurgitation was reported.The investigation found that cusp 1 and 2 were torn.Information from the field confirmed that one cusp was observed to be perforated upon explant.There was circumferential fibrous pannus ingrowth on the inflow and outflow surfaces which extended onto cusp 2.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the perforation could not be conclusively determined; however, the tears in cusp 1 and cusp 2 were associated with degenerative changes at the tear site including a denatured appearance in collagen and a marked thinning and loss of collagen fibers at the test site of the tear.In addition, the fibrous pannus ingrowth noted had the potential to induce increased stress on adjacent cusps and create an unbalanced stress relief distribution between all cusps during coaptation, leading to cusp tears and reduced durability.There is no indication of a product quality issue with regards to manufacture, design, or labeling.H6.Medical device problem code 4008 a0414 material split, cut or torn was removed.
|